
Japan-based pharma firm Taiho Oncology has appointed Tim Whitten to the position of senior vice president and chief commercial officer. …

The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

Doctors are warning that patients and members of their own profession are increasingly turning to Wikipedia for medical information, but …
Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …

Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …

Amersham-based UK medical education company Wave has appointed three new members of staff. Charlotte Wilkinson joins as programme manager and …

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …

Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …

A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …

Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …